JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (11): 33-37.doi: 10.6040/j.issn.1671-7554.0.2014.194

Previous Articles     Next Articles

Dynamics of fasting glucagon and fasting glucagon /insulin ratio with diabetes duration in patients with type 2 diabetes

TIAN Meng, WU Chuanlong, QI Lin, LIU Yan, WANG Chuan, ZHAO Ruxing, LIANG Kai, SONG Jun, HOU Xinguo, CHEN Li   

  1. Department of Endocrinology, Qilu Hospital of Shangdong University, Jinan 250012, Shandong, China
  • Received:2014-04-08 Published:2014-11-10

PDF (PC)

203

Abstract: Objective To analyze the dynamics of fasting glucagon (FGLC) and glucagon /insulin (FGLC/FINS) ratio with diabetes durations and their correlations with glycemic control in patients with type 2 diabetes. Methods Two hundred and sixty-two patients with type 2 diabetes were enrolled and divided into five groups according to diabetes duration: <5 years (group A, n=65); ≥ 5 years and <10 years (group B, n=62); ≥10 years and <15 years (group C, n=46); ≥15 years and <20 years (group D, n=45);≥20 years (group E, n=44). FGLC, fasting insulin (FINS), FGLC/FINS ratio, C peptide, HOMA-IR, HOMA-β and other metabolic indicators were measured to explore their correlations with diabetes duration, fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c). Results FGLC levels of groups A, B and C increased progressively with diabetes duration(r=0.243, P<0.05). Oppositely, FGLC levels of groups D and E were lower than that of group C (P<0.05) and were not correlated with diabetes duration. FGLC/FINS ratio was positively correlated with diabetes duration (r=0.243, P<0.05). Multiple stepwise regression analysis showed that the FGLC/FINS ratio was positively correlated with FBG and HbA1c (t=4.474 or 2.212, P<0.05). Conclusion FGLC of patients with type 2 diabetes increased with diabetes duration forthe first 15 years since being diagnosed, then slightly decreased, whereas the FGLC/FINS ratio consistently increased with diabetes duration. The FGLC/FINS ratio might significantly affect the glycemic control in patients with type 2 diabetes.

Key words: Type 2 diabetes, Glucagon, Glucagon/insulin ratio, Duration

CLC Number: 

  • R587.1
[1] DAlessio D. The role of dysregulated glucagon secretion in type 2 diabetes[J]. Diabetes Obes Metab, 2011, 13(1):126-132.
[2] Kaku K, Kawasaki F, Kanda Y, et al. Retained capacity of glucose-mediated insulin secretion in patients with type 2 diabetes mellitus inversely correlates with the duration of diabetes[J]. Diabetes Res Clin Pract, 2004,64(3):221-223.
[3] Wallace T M, Levy J C, Matthews D R. Use and abuse of HOMA modeling[J]. Diabetes Care, 2004, 27(6):1487-1495.
[4] Ramnanan C J, Edgerton D S, Kraft D, et al. Physiologic action of glucagon on liver glucose metabolism[J]. Diabetes Obes Metab, 2011, 13(1):118-125.
[5] Lee Y, Berglund E D, Wang M Y, et al. Metabolic manifestations of insulin deficiency do not occur without glucagon action[J]. Proc Natl Acad Sci U S A, 2012,109(37):14972-14976.
[6] Fridlyand L E, Philipson L H. A computational systems analysis of factors regulating α cell glucagon secretion[J]. Islets, 2012, 4(4):262-283.
[7] Walker J N, Ramracheya R, Zhang Q, et al. Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?[J]. Diabetes Obes Metab, 2011, 13(1):95-105.
[8] Kawamori D, Kulkarni R N. Insulin modulation of glucagon secretion: the role of insulin and other factors in the regulation of glucagon secretion[J]. Islets, 2009, 1(3):276-279.
[9] Menge B A, Grüber L, Jrgensen S M, et al. Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes[J]. Diabetes, 2011, 60(8):2160-2168.
[10] Christensen M, Vedtofte L, Holst J J, et al. Glucose-dependent insulinotropic polypeptide:a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans[J]. Diabetes, 2011, 60(12):3103-3109.
[11] 项守奎, 朱大龙. α细胞、胰高血糖素与2型糖尿病[J]. 医学研究生学报, 2010, 23(4): 440-443. XIANG Shoukui, ZHU Dalong. Alpha-cells, glucagon and type 2 diabetes[J]. J Med Postgra, 2010, 23(4):440-443.
[12] Shen X X, Li H L, Pan L, et al. Glucotoxicity and α cell dysfunction: involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal αTC1-6 cells[J]. Endocr Res, 2012, 37(1):12-24.
[13] 杜瑞琴, 李宏亮, 杨文英, 等. 吡格列酮对胰岛α细胞胰岛素抵抗的影响[J]. 中华内分泌代谢杂志, 2008,24(1):29-33. DU Ruiqin, LI Hongliang, YANG Weiying, et al. Effect of pioglitazone on islet α cell with respect to insulin resistance[J]. Chin J Endocrinol Metab, 2008, 24(1): 29-33.
[14] Gosmain Y, Masson M H, Philippe J. Glucagon: the renewal of an old hormone in the pathophysiology of diabetes[J]. J Diabetes, 2013, 5(2): 102-109.
[15] 郭航, 常宝成, 杨菊红, 等. 不同病程2型糖尿病患者胰岛α及β细胞功能评价[J]. 中华全科医师杂志, 2013,12(11):874-877. GUO Hang, CHANG Baocheng, YANG Juhong, et al. Functions of pancreatic islet a-cells and β-cells in different disease courses of type 2 diabetes mellitus[J]. Chin J Gen Pract, 2013, 12(11):874-877.
[16] 孙晔子, 王粹芳, 崔世维. 胰高血糖素在2型糖尿病发展中的作用探讨[J]. 山西医药杂志, 2008, 37(12):1119-1121.
[17] Zhang Y, Hu G, Yuan Z, et al. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis[J]. PLoS One, 2012, 7(8):e42551. doi: 10.1371/journal.pone.0042551.
[18] 袁岩, 顾海军, 钱燕宁. 糖化血红蛋白与糖尿病并发症相关性的研究进展[J]. 实用临床医药杂志, 2011, 15(19):186-189.
[1] SU Ping, YANG Yachao, YANG Yang, JI Jiadong, DAYIMU Alimu, LI Min, XUE Fuzhong, LIU Yanxun. Prediction models on the onset risks of type 2 diabetes among the health management population [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(6): 82-86.
[2] LI Shuai, WANG Yalin, SUN Zhongwen, ZHU Meijia. Expression changes and mechanism of Nod-like receptor protein 3 inflammasome in the cerebral microvascular endothelial cells in type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 6-11.
[3] YANG Yang, ZHANG Guang, ZHANG Chengqi, SONG Xinhong, XUE Fuzhong, WANG Ping, WANG Li, LIU Yanxun. A prediction model for type 2 diabetes risks: a cohort study based on health examination [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 69-72.
[4] PENG Li, QIANG Ye, ZHAO Huichen, CHEN Shihong, YAO Weidong, LIU Yuantao. Clinical studies on type 2 diabetic patients treated with sitagliptin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 60-63.
[5] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[6] Muhadasi TUERXUNYIMING, Patamu MOHEMAITI, Tuolanguli MAIMAITIKUERBAN. Association of CDKAL1 rs10946398 C/A polymorphism with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 75-85.
[7] YU Ning, GAO Yanyan, XIAN Yuxin, NIU Jiapeng, LI Li, WANG Jing, CAO Caixia. Effect of exenatide on serum chemerin level and liver fat contents in type 2 diabetes mellitus combined with non-alcoholic fatty liver disease patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 51-55.
[8] ZHANG Li, ZHU Huiming, WANG Yanmei, JIANG Di, SUN Xianjiu, LE Youlin. Relationship between abdominal distension and small intestine bacterial overgrowth in type 2 diabetic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 45-47.
[9] LIU Yanxun, LIU Jia, ZHANG Tao, WANG Lu, XUE Fuzhong, WANG Ping. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(8): 83-86.
[10] YAO Zhina, HAN Ting, FAN Xiuling, ZHANG Yousheng, SONG Jialun. Effect of Glucagon-like peptide-1 on ovarian circadian clock rhythm of rats fed with high fat diet [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 19-21.
[11] PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42.
[12] HU Fangzhi, ZHANG Zhengjun, GENG Houfa, LIANG Qiuhua, SUN Lin. Relationship between microalbuminuria and brain damage in patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 43-47.
[13] LI Fang. Association between receptor of advanced glycation end products gene polymorphisms, soluble receptor of advanced glycation end products and susceptibility of type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 57-61.
[14] LI Hanbing, GAO Yanyan, LI Li, CAO Caixia, XIAN Yuxin, WANG Jing, NIU Jiapeng. Effect of lansoprazole and exenatide on gastrin and oxyntomodulin in patients with type 2 diabetes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 64-68.
[15] HAN Wenjie1, YU Suguo1, CUI Xiangyu2. Effects of N-acetylcysteine on GLP-1 and IL-6 in high-fat-diet rats with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 12-16.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd